StockData
Curaleaf Holdings, Inc. logo

Curaleaf Holdings, Inc. (CURLF) stock

CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026Market cap $2.07BP/E –Yield –

Earnings

Curaleaf's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q3 FY2026
$352.70M
EPS, Q3 FY2026
-$0.14
Latest guidance
Issued
Nov 3, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Curaleaf's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 3, 2026after the close$352.70M–-$0.14Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$340.00M–$0.05Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Curaleaf's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
operating cash flowGAAPFY2026$150.00M–NewNov 3, 2026

Guidance history

Every forecast Curaleaf put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 3, 2026operating cash flowFY2026$150.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Curaleaf filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. Results
  4. Update
  5. News
  6. News
  7. News
  8. News
  9. News
  10. Update
  11. Update
  12. News
  13. News
  14. News
  15. News

See a number that looks wrong?